In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Shareholder Activism Appendix

Executive Summary

A complete list of the companies included in EY's shareholder return analysis.

The following companies were included in the total shareholder return analysis (listed in alphabetical order by subsector):

Big Pharma: AstraZeneca PLC, Bristol-Myers Squibb Co., Eli Lilly & Co. Inc., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Roche, Sanofi

Big Biotech: Alexion Pharmaceuticals Inc., Amgen Inc., Biogen Inc., BioMarin Pharmaceutical Inc., Celgene Corp., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Seattle Genetics Inc., Shire PLC, Vertex Pharmaceuticals Inc.

Specialty Pharma/Generics: Actavis PLC, Allergan Inc., Endo International PLC, Forest Laboratories Inc., Hospira Inc., Jazz Pharmaceuticals PLC, Mylan Inc., Perrigo Co., Salix Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc.

Four companies in the above list were activist targets during 2013 and 2014: Allergan, Amgen, Forest Laboratories, and Teva Pharmaceutical Industries. Total shareholder returns for these four companies were used to calculate the median total shareholder return for activist targets.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts